BRUSSELS (REUTERS) - Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its Covid-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.

Any delay would be a further blow to EU's vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow roll-out of shots in many member states.